FDA updates label of diabetes drug Ozempic to acknowledge reports of intestinal blockage in some
The drug mimics a hormone the body naturally makes to slow the digestion of food, helping people feel fuller for longer.
•
Sep 28, 2023, 12:44 PM
•
Updated 302 days ago
Share:
More Stories
1:30
Officials: Calls to 988 have increased since its creation 2 years ago
5ds ago1:41
Officials: COVID-19 has hit high levels in several states, including Connecticut
6ds ago2:03
Poll: More than 40% of women skip or delay medical screenings and appointments
12ds ago1:59
New Alzheimer's drug shown to reduce memory loss for some patients
19ds ago1:59
Study: Eating ultra-processed foods can shorten your lifespan
20ds ago1:29
Staying hydrated – what to drink depends on your level of physical activity, doctor says
26ds ago1:30
Officials: Calls to 988 have increased since its creation 2 years ago
5ds ago1:41
Officials: COVID-19 has hit high levels in several states, including Connecticut
6ds ago2:03
Poll: More than 40% of women skip or delay medical screenings and appointments
12ds ago1:59
New Alzheimer's drug shown to reduce memory loss for some patients
19ds ago1:59
Study: Eating ultra-processed foods can shorten your lifespan
20ds ago1:29
Staying hydrated – what to drink depends on your level of physical activity, doctor says
26ds agoThe Food And Drug Administration has just updated the label of the popular diabetes drug Ozempic.
The label now includes recent reports of blocked intestines in some people using the drug.
Ozempic, and its sister drug Wegovy, used for weight loss, have recently sky rocketed in popularity.
The two drugs mimic a hormone the body naturally makes to slow the digestion of food, helping people feel fuller for longer.
The label for Wegovy already acknowledged reports of intestinal blockage for some.
